Thursday, 21 December 2017

Major Advantage of Surgical Sealants and Adhesives Device Is To Manage Blood Loss In Patients

Major Factor Which Are Driving The Growth Of Surgical Sealants and Adhesives Market :
Increasing incidence of chronic diseases along with the rapid growth in the geriatric population, increasing need manage blood loss in patients, and growing number of surgical procedures performed are the major factors driving the growth of the surgical sealants and adhesives market
Get PDF Brochure Here : http://bit.ly/2hMM8eA
On the basis of product, the market is segmented into natural/biological sealants and adhesives and synthetic & semi-synthetic sealants and adhesives. The natural/biological sealants and adhesives segment is further categorized into type and origin.
On the basis of type, the natural/biological sealants segment have been divided into polypeptide/protein-based and polysaccharide-based sealants and adhesives. The polypeptide/protein-based sealants segment is further categorized into fibrin, gelatin, collagen, and albumin-based adhesives, while the polysaccharide-based sealants segment comprise of chitosan-based and other polysaccharide-based adhesives.
 On the basis of origin, the natural/biological sealants and adhesives segment is categorized into human blood-based and animal-based. The synthetic and semi-synthetic sealants and adhesives segment is divided into cyanoacrylates, polyethylene glycol hydrogels, urethane-based adhesives, and other synthetic adhesives.
On the basis of application, the global surgical sealants and adhesives market is segmented into CNS, general, cardiovascular, orthopedic, cosmetic, urological, pulmonary, ophthalmic surgeries, and other applications.


To Know More : http://bit.ly/2fuaGZi

Tuesday, 19 December 2017

Future of Parkinson's Disease Treatment Market

Parkinson’s disease therapeutic drugs act upon the central nervous system to control or reduce the symptoms of Parkinson’s disease. The global Parkinson’s disease treatment market is expected to reach USD 5.69 billion by 2022 from USD 4.24 billion in 2017, at a CAGR of 6.1%.


Globally, the Parkinson’s disease treatment market is witnessing a moderate growth due to factors such as increasing prevalence of Parkinson’s disease; rising geriatric population; and support for research on Parkinson’s disease. 

Over the last few decades, key players operating in this market are focusing on offering new and innovative products. Based on drug class, the Parkinson’s disease therapeutic drugs market is segmented into carbidopa/levodopa dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs. The carbidopa/levodopa segment is expected to register the highest CAGR during the forecast period. This is due to carbidopa/levodopa drugs are more potent and widely used in the treatment of Parkinson’s disease in comparison to other therapeutic drugs.

By distribution channel, the market is segmented into hospital pharmacies, retailer pharmacies, and online pharmacies. The online pharmacies segment is expected to register the highest growth rate during the forecast period. Advancements such as 24/7 availability, home delivery, and discount on medicines are driving factors for online pharmacies segment.


On the basis of patient care setting, the market is categorized into hospitals and clinics. The hospitals segment is estimated to grow at the fastest rate during the forecast period. The growth of this segment can be attributed to the availability of diagnostics laboratories in the hospital and the presence skilled neurologists.


The Parkinson’s disease treatment market is classified based on regions into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. Presence key market players and rising aging population are the major factors driving the Parkinson’s disease treatment market in this region. 

Monday, 27 November 2017

Global Thermal Analysis Market Top Industry Key Players Analysis 2017-22

Download PDF Brochure: http://bit.ly/2zsH47D



The global thermal analysis market is expected to grow at a CAGR of 4.6% between 2017 and 2022. Factors such as increasing production of crude and shale oil, patent expiry of blockbuster drugs and biomolecules, and stringent food and product safety regulations are driving the thermal analysis market.
Analysis of the market developments between 2014 and 2017 revealed that several growth strategies such as product launches, enhancements, strategic acquisitions, agreements, contracts, partnerships, collaborations, and expansions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the thermal analysis market.
As of 2016, Waters (US), NETZSCH (Germany), LINSEIS Germany), Mettler-Toledo (US), PerkinElmer (US), SETARAM (France), and Shimadzu (Japan) held the leading position in the global thermal analysis market. These companies adopted product launches, agreements, partnerships, and collaborations as their key growth strategies in the past three years. Hitachi (Japan), Theta (US), Nanjing Dazhan (China), Instrument Specialists (US), Rigaku (Japan), LECO (US), and Innuo (China) are some of the other major players in this market.
Waters (US) held the leading position in the global thermal analysis market in 2016. The company is one of the top players in the thermal analysis market due to its robust product portfolio that includes all major types of analyzers. NETZSCH (Germany) was among the top players in the global thermal analysis market in 2016.
Download Free Sample Pages of Report: http://bit.ly/2hNCBkK

Sunday, 5 November 2017

Spine Biologics Market by Product & End User – 2020

The report "Spine Biologics Market by Product Type (Bone Graft, Bine Graft Substitute, Platelet Rich Plasma, BMAC), Surgery Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), End User, and Geography - Global Forecast to 2020", The global spine biologics market was valued at $1.90 Billion in 2014 and is expected to reach $2.4 Billion by 2020, at a CAGR of 4.4% during the forecast period of 2015 to 2020.

Browse 55 market data tables and 54 figures spread through 101 pages and in-depth TOC on "Spine Biologics Market”
http://www.marketsandmarkets.com/Market-Reports/spine-biologics-market-67680943.html
Early buyers will receive 10% customization on This report.

Spinal biologics encompass materials that can be utilized in case of bone fusion surgery, spinal cord injury, and degenerative disk disease. Ten years ago, the spine treatment market constituted 75% traditional rods and plates made of metals and 25% biologics. However, since metals are inert materials, they did not stimulate the bone regeneration process. On the other hand, biological materials are proteins that can attract and stimulate cells, promote fusion, and help in the bone healing process

By product type, the spine biologics market is categorized into four types, namely, bone graft substitutes, bone grafts, platelet-rich plasma (PRP), and bone marrow aspirate concentrate therapy. In 2014, the bone graft substitutes segment contributed the largest share of 84.1% to the global market.

Download PDF Brochure : http://bit.ly/2yVrI7Z

By surgery type, the market is segmented into: anterior cervical discectomy and fusion (ACDF), transforaminal lumbar interbody fusion (TLIF), anterior lumbar interbody fusion (ALIF), lateral lumbar interbody fusion (LLIF), and other surgeries. The ACDF segment contributed the largest share to the global spine biologics market in 2014, followed by the transforaminal lumbar interbody fusion (TLIF) segment.

The spine biologics devices are used in spine surgery as lieu allografts as well as a support for bones in and around the spinal region. These devices offer numerous benefits over materials such as pedicle rods and screws that are used in spine fusion. Since metals are inert in nature, they do not stimulate or activate cellular growth or alter cellular functions such as natural healing. Spine biologics, on the other hand, activate cellular growth by stimulating spine fusion.

The driving forces for global spinal biologics market include rising incidence of spinal disorders, rising healthcare expenditure in developing nations owing to growing income levels, rising obesity cases, awareness on the newly developed spine treatment techniques and devices, technological advancements, and rising demand of minimally invasive spine surgeries. The major restraints for this market include lack of expertise, lack of patient awareness, cost of surgery, and unfavourable reimbursement scenario.

The global spine biologics market has been categorized by regions into North America, Europe, Asia-Pacific, and the Rest of the World. North America is the most dominant region in the global market, followed by Europe. Bone graft substitute segment dominated the North American spine biologics market.

Some of the major players in the spine biologics market are Medtronic Inc. (U.S.), DePuy Synthes Companies (U.S.), Zimmer Holding Inc. (U.S.), Nuvasive Inc. (U.S.), Stryker Corporation (U.S.), Orthofix international N.V. (U.S.), K2M Inc. (U.S.), Exactech Inc. (U.S.), Wright Medical Technology Inc. (U.S.), and others.

To Know More : http://bit.ly/2xd8Qz5

Wednesday, 1 November 2017

Significant Growth in Pharmacovigilance and Drug Safety Software Market

The report “Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) - Global Forecast to 2019”

The global pharmacovigilance and drug safety software market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of $154.1 Million in 2019.

Browse 74 market data tables and 57 figures spread through 210 pages and in-depth TOC on
“Pharmacovigilance and Drug Safety Software Market“
http://www.marketsandmarkets.com/Market-Reports/drug-safety-pharmacovigilance-software-market-16831714.html
Early buyers will receive 10% customization on this reports.

In this report has been classified into many segments on the basis of functionality, namely, adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software. The global pharmacovigilance and drug safety software market is divided into two segments on the basis of delivery mode, namely, on-premise delivery mode and on-demand/cloud based (SaaS) delivery mode.
The global pharmacovigilance and drug safety software market is also segmented on the basis of end users including pharma and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, and other pharmacovigilance service providers.

The Sample Report For This Report@
http://www.marketsandmarkets.com/requestsample.asp?id=16831714

Factors such as rising incidence rates of adverse drug reactions (ADRs) and increasing adoption of pharmacovigilance software by outsourcing companies are driving the growth of the global pharmacovigilance and drug safety software market. In addition; government regulatory bodies (such as the U.S. FDA and EMEA) have intensified safety regulations for prior and post commercialization of drugs, which has increased pressure on the pharmaceutical and biotechnology companies to manufacture safe drugs and evaluate their results post sales.

Thus, growing complexity related to drug safety regulations is expected to drive the growth of the market during the forecast period.

Geography:
North America holds the largest share of the global pharmacovigilance and drug safety software market, followed by Europe. However, Asian and Latin American countries represent high growth markets, owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations.

Get The PDF Brochure For This Report@
http://www.marketsandmarkets.com/pdfdownload.asp?id=16831714

ArisGlobal (U.S.), Ennov Solutions Inc. (U.S.), EXTEDO GmbH (U.S.), Online Business Applications, Inc. (U.S.), Oracle Corporation (U.S.), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (U.S.), and United BioSource Corporation (U.S.) are some of the key players in the global pharmacovigilance and drug safety software market.

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. 

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441

Tuesday, 24 October 2017

Parkinson's Disease Treatment Market Worth 5.69 Billion USD by 2022

Parkinson’s disease therapeutic drugs act upon the central nervous system to control or reduce the symptoms of Parkinson’s disease. The global Parkinson’s disease treatment market is expected to reach USD 5.69 billion by 2022 from USD 4.24 billion in 2017, at a CAGR of 6.1%.




Globally, the Parkinson’s disease treatment market is witnessing a moderate growth due to factors such as increasing prevalence of Parkinson’s disease; rising geriatric population; and support for research on Parkinson’s disease. 

Over the last few decades, key players operating in this market are focusing on offering new and innovative products. Based on drug class, the Parkinson’s disease therapeutic drugs market is segmented into carbidopa/levodopa dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs. The carbidopa/levodopa segment is expected to register the highest CAGR during the forecast period. This is due to carbidopa/levodopa drugs are more potent and widely used in the treatment of Parkinson’s disease in comparison to other therapeutic drugs.

By distribution channel, the market is segmented into hospital pharmacies, retailer pharmacies, and online pharmacies. The online pharmacies segment is expected to register the highest growth rate during the forecast period. Advancements such as 24/7 availability, home delivery, and discount on medicines are driving factors for online pharmacies segment.


On the basis of patient care setting, the market is categorized into hospitals and clinics. The hospitals segment is estimated to grow at the fastest rate during the forecast period. The growth of this segment can be attributed to the availability of diagnostics laboratories in the hospital and the presence skilled neurologists.


The Parkinson’s disease treatment market is classified based on regions into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. Presence key market players and rising aging population are the major factors driving the Parkinson’s disease treatment market in this region. 

HIP Replacement Market Forecast to 2020

The report "HIP Replacement Market by Product (Primary HIP Replacement (Cemented, Cementless), Partial HIP Replacement, Revision HIP Replacement, HIP Resurfacing), Geography (Americas, EU-5, Japan, BRIC, South-East Asia, MEA) - Forecast to 2020", The global hip reconstruction devices market was valued at USD 4.8 Billion in 2014, and is estimated to reach USD 5.9 Billion by 2020, at a CAGR of 3.0% from 2015 to 2020.

Browse 105 market data tables and 114 figures spread through 228 pages and in-depth TOC on "HIP Replacement Market”
http://www.marketsandmarkets.com/Market-Reports/hip-reconstruction-devices-market-76831539.html
Early buyers will receive 10% customization on reports.

The Global Hip Reconstruction Devices market is expected to witness substantial growth due to increasing number of arthritis patients, favorable reimbursement, and technological advancements

The global hip reconstruction devices market growth is attributed to the rise in the number of patients suffering from arthritis, technological advancements, and favorable reimbursement. Despite this, the pricing pressure, waiting list and risk of complications after implantation are some of the major hindering factors.

The government initiative of allocating new funds and development of new policies have reduced the waiting time for hip reconstructions, and increased the number of operations. However, it is difficult to achieve 90% threshold of patients that receive care within the regulated time.

Get PDF Brochure Here :
http://www.marketsandmarkets.com/pdfdownload.asp?id=76831539

The technological advancements in hip reconstruction market, such as newly developed prostheses with improved strength and reliability of joints are reducing the need and cost of revision surgery. The minimally invasive techniques for hip reconstruction surgery will improve the precision and accuracy of surgeons, thus reducing the time of surgery. The emergence of these techniques and other improved surgical tools for the treatment of arthritis is expected to address the rising demand for surgery during the forecast period.

In 2014, the global hip reconstruction devices market was dominated by North America. This market is segmented and forecast on the basis of product, and geography. The product comprises of primary hip reconstruction devices, partial hip reconstruction devices, revision hip reconstruction devices and hip resurfacing devices. The primary hip reconstruction devices are subsegmented into cementless and cemented reconstruction device. The market is further segmented and forecast on the basis of major geographies such as North America, Europe, and Asia-Pacific. These major geographies are further sub-segmented into major countries.

The market in North America is growing due to rising pool of arthritis, and favorable reimbursement. The European market is growing due to the technological advancements and is dominated majorly by Zimmer Inc. (U.S.) and Depuy Synthes (U.S.). The Asian market is growing due to growing health awareness among masses, along with increase in the spending capacity of the Indian population. Also, increasing number of population suffering from musculoskeletal disorders (MSD), government initiatives, and rising awareness towards hip reconstruction are propelling the market growth.

Get Sample Report Here :
http://www.marketsandmarkets.com/requestsample.asp?id=76831539

This report also includes the market share, approach for arriving at the market size, new technology developments, product matrix, life cycle analysis, Porter’s five forces analysis and price analysis by product. In this report, market metrics are also included such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market including major companies which provide hip reconstruction devices as a product.

The research study is aimed at identifying emerging trends and opportunities in the global hip reconstruction devices market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global hip reconstruction devices market, on the basis of product, and region.

About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Patient Portal Market Size, Market Growth Projection to 2023

The growth of the overall patient portals market can be contributed to the federal mandates like meaning use, growing patient centric appro...